Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Releases.
Press releases published on August 12, 2025

Medical Courier Market Forecast : $16,237.27 Million by 2032 with 6.42% Growth Rate
WILMINGTON, NEW CASTLE, DE, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, "Medical Courier Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product Type, …

Ridge Oral Surgery's recent event focused on minimizing dental implant complications through professional development
Over 30 dentists joined the Ridge Oral Surgery Study Club to learn cutting-edge dental implant techniques from renowned prosthodontist Dr. Shankar Iyer BASKING RIDGE, NEW JERSEY, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- Ridge Oral Surgery is …

Ridge Oral Surgery Celebrates Two-Year Anniversary
Top-rated oral surgery practice in Basking Ridge, New Jersey, marks two years of exceptional patient care and service BASKING RIDGE, NJ, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- Ridge Oral Surgery is proud to celebrate its two-year …

High School Athlete’s Mysterious Illness Leads to Rare Diagnosis of idiopathic Multicentric Castleman Disease (iMCD)
iMCD is one of the main subtypes of Castleman disease BRIDGEWATER, NJ, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- Idiopathic multicentric Castleman disease (iMCD) is a rare, sometimes life-threatening disorder that affects all ages. Its …

Dr. Sam Speron Highlights Medical and Emotional Impacts of Otoplasty in New Discussion
Dr. Sam Speron Highlights Medical and Emotional Impacts of Otoplasty in New Discussion CHICAGO, IL, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- Dr. Sam Speron, a board-certified plastic and reconstructive surgeon, highlights the transformative …

Dr. Angelin Chang Unveils Rapid Breakthrough Method to Help Musicians Play Pain-Free
CLEVELAND, OH, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- Dr. Angelin Chang, GRAMMY® Award-winning pianist and elite performance specialist, is transforming how musicians reclaim their artistry, heal from pain, and overcome technical …

Maximus Ranks No. 27 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
Los Angeles, CA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced Maximus is No. 27 on the annual Inc. 5000 list, the most prestigious ranking of the …

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in H2 2026 Announced positive data from Phase 1b/2a RESOLVE supporting the potential of EP-104GI to improve the standard of …

Venous Stents Market to Reach $2.62B by 2033, Fueled by Minimally Invasive Trends and Aging Populations
Market to grow at 8.5% CAGR as tech advances, early diagnosis, and vascular care demand drive adoption globally. LOS ANGELES, CA, UNITED STATES, August 12, 2025 /EINPresswire.com/ -- The Venous Stents Market reached US$ 1.24 billion in 2024 and is …

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
• First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026 • Cadisegliatin intellectual property portfolio expanded • Leadership team …

First Lady Anna Stein, NCDHHS and Morse Clinics Celebrate First Mobile Opioid Treatment Program Unit in North Carolina
Raleigh, NC, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Credentialed media are invited to attend the unveiling of the first Mobile Opioid Treatment Program (OTP) unit in North Carolina. Mobile OTPs reduce barriers to participation in treatment by making it easier …

Sienna Reports Second Quarter 2025 Financial Results and Publishes 2025 Impact Report
MARKHAM, Ontario, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced its financial results for the three and six months ended June 30, 2025. Highlights Average Same Property Occupancy in …

PetMed Express, Inc. Announces Management Changes
DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, Sandra Campos, and Chief Financial Officer, Robyn D’Elia …

Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates
- Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to discuss regulatory pathways with U.S. FDA in Q4 2025 - - FA (SGT-212): Phase 1b trial initiation expected in Q4 2025 - - CPVT (SGT- …

ImmuCell Announces Bank Debt Refinancing
PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

Zevra Reports Second Quarter 2025 Financial Results and Corporate Update
Q2 2025 net revenue of $25.9 million, driven by product net revenue of $21.8 million Completed sale of PRV for $150.0 million, bolstering the balance sheet as the Company executes on its commercial launches and development programs Submitted a Marketing …

LogicMark, Inc. Reports Second Quarter 2025 Results Highlighted by 22% Sales Growth
LOUISVILLE, Ky., Aug. 12, 2025 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK) (the Company), a provider of personal safety, personal emergency response systems (PERS), health communications devices, and technology for the growing care and safety economy, …

Cue Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Received FDA feedback on Pre-IND Briefing Document reinforcing Company’s intention to advance investigational new drug (IND) submission for CUE-401 to address unmet need in the treatment of autoimmune disease. Announced strategic research collaboration and …

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
– Multiple near-term potential milestones, including anticipated completion of primary structure analysis and select functional analyses in 3Q’25 – – Type 2a meeting with the FDA anticipated in 4Q’25– – Cash runway expected to support operations through …

ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
– Data from ASPEN-06 trial highlights CD47 expression as a key predictive biomarker of greater response to evorpacept in HER2+ Gastric Cancer; updated data to be presented at a medical conference in Q4 2025 – Phase 2 ASPEN-Breast evorpacept trial design …